series-c-plus
Stage
2018
Founded
4
Investors
About
Genalyte develops a fully automated, on-site blood diagnostic testing device called Merlin that delivers accurate lab results within 30 minutes directly at the point of care, integrating seamlessly with electronic medical records.
Explore Genalyte's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.